Title: |
Randomized phase II trial of TEGAFIRI (tegafur/uracil, oral leucovorin, irinotecan) compared with FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) in patients with unresectable/recurrent colorectal cancer |
Source: |
International Journal of Cancer
[0020-7136]
Shigeta,
Kohei
yr:2016
|
|
|
|